文献速递衰弱、肌少症与跌倒老年综合评估

社区老年人肌少症患病率:不同定义间的系统综述与Meta分析

The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses.
PubMed 文献 · Age Ageing · 2019-01-01

该系统综述纳入109篇文章,识别出8种肌少症定义,并按性别和族裔分层估计患病率。不同定义下社区老年人肌少症合并患病率从9.9%到40.4%不等,欧洲/亚洲工作组定义最低(12.9%),四肢骨骼肌量/体重定义最高(40.4%)。研究间差异主要来源于参与者年龄和肌肉量切点,定义间缺乏一致性限制了临床使用。

要点

  • 社区老年人肌少症患病率因定义不同差异巨大,范围9.9%至40.4%。
  • 欧洲/亚洲工作组定义合并患病率12.9%,国际工作组定义9.9%。
  • 四肢骨骼肌量/体重定义患病率最高达40.4%,切点和年龄是异质性来源。

核心结论

  • 社区老年人肌少症患病率估计值随所用定义变化,范围为9.9%至40.4%,定义间缺乏一致性,需在临床使用前更好理解。

研究设计与样本

  • 系统综述与Meta分析,纳入109篇估计社区老年人肌少症患病率的文章,按性别和族裔分层估计各定义合并患病率,并分析研究间及定义内差异。

主要发现

  • 共识别出8种肌少症定义,最低合并患病率见于欧洲工作组/亚洲工作组定义(12.9%,95%CI 9.9-15.9%)、国际工作组定义(9.9%,95%CI 3.2-16.6%)和Foundation for the National Institutes of Health定义(18.6%,95%CI 11.8-25.5%)。
  • 最高患病率见于四肢骨骼肌量(ALM)/体重定义(40.4%,95%CI 19.5-61.2%)、ALM/身高定义(30.4%,95%CI 20.4-40.3%)、ALM对身高和体重回归定义(30.4%,95%CI 20.4-40.3%)及ALM/体质指数定义(24.2%,95%CI 18.3-30.1%)。
  • 定义内研究间差异的主要来源为研究参与者年龄和所用肌肉量切点。

关键数值与推荐

  • 欧洲工作组/亚洲工作组定义合并患病率12.9%(95%CI 9.9-15.9%)。
  • 国际工作组定义合并患病率9.9%(95%CI 3.2-16.6%)。
  • Foundation for the National Institutes of Health定义合并患病率18.6%(95%CI 11.8-25.5%)。
  • ALM/体重定义合并患病率40.4%(95%CI 19.5-61.2%)。
  • ALM/身高定义合并患病率30.4%(95%CI 20.4-40.3%)。

临床怎么用

  • 临床评估社区老年人肌少症时需注意所用定义,不同定义患病率差异大,应结合年龄和肌肉量切点解读结果。

局限性

  • 定义间缺乏一致性,研究间异质性来源于年龄和肌肉量切点,需进一步理解后才能将肌少症定义恰当用于临床。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: sarcopenia in ageing is a progressive decrease in muscle mass, strength and/or physical function. This review aims to summarise the definitions of sarcopenia in community-dwelling older adults and explore similarities and differences in prevalence estimates by definition. METHODS: a systematic review was conducted to identify articles which estimated sarcopenia prevalence in older populations using search terms for sarcopenia and muscle mass. Overall prevalence for each sarcopenia definition was estimated stratified by sex and ethnicity. Secondary analyses explored differences between studies and within definitions, including participant age, muscle mass measurement techniques and thresholds for muscle mass and gait speed. RESULTS: in 109 included articles, eight definitions of sarcopenia were identified. The lowest pooled prevalence estimates came from the European Working Group on Sarcopenia/Asian Working Group on Sarcopenia (12.9%, 95% confidence interval: 9.9-15.9%), International Working Group on Sarcopenia (9.9%, 3.2-16.6%) and Foundation for the National Institutes of Health (18.6%, 11.8-25.5%) definitions. The highest prevalence estimates were for the appendicular lean mass (ALM)/weight (40.4%, 19.5-61.2%), ALM/height (30.4%, 20.4-40.3%), ALM regressed on height and weight (30.4%, 20.4-40.3%) and ALM / body mass index (24.2%, 18.3-30.1%) definitions. Within definitions, the age of study participants and the muscle mass cut points used were substantive sources of between-study differences. CONCLUSION: estimates of sarcopenia prevalence vary from 9.9 to 40.4%, depending on the definition used. Significant differences in prevalence exist within definitions across populations. This lack of agreement between definitions needs to be better understood before sarcopenia can be appropriately used in a clinical context.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Mayhew AJ, Amog K, Phillips S, et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2019. PMID: 30052707. doi:10.1093/ageing/afy106

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。